## **Core Concept**
Ovarian Hyperstimulation Syndrome (OHSS) is a potentially life-threatening complication that can occur in women undergoing fertility treatment, particularly those receiving injections to stimulate the release of eggs from the ovaries. It is characterized by enlarged ovaries and the release of chemicals that can cause fluid shifts and lead to various systemic symptoms. The condition is closely associated with the use of medications that stimulate ovarian follicle growth.

## **Why the Correct Answer is Right**
The correct answer, **Clomiphene and Gonadotropins**, is right because both are known to stimulate the ovaries to produce multiple follicles, which can lead to OHSS, especially when excessive stimulation occurs. Clomiphene acts by binding to estrogen receptors in the hypothalamus, leading to an increase in gonadotropin release, which in turn stimulates the ovaries. Gonadotropins, such as FSH and LH, directly stimulate the ovaries to grow follicles. When used in fertility treatments, there's a risk of over-stimulation, leading to OHSS.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, any option not directly related to ovarian stimulation for fertility treatments would be incorrect.
- **Option B:** This option is also not provided, but similar reasoning would apply; any medication not directly implicated in stimulating ovarian follicle growth or known to cause OHSS would be incorrect.
- **Option D:** Without the specific details of Option D, it's difficult to provide a direct explanation. However, generally, any medication not directly associated with the stimulation of ovarian follicles or known to induce OHSS would be considered incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that OHSS is more commonly associated with the use of **gonadotropins** (like FSH and LH) than with clomiphene alone. However, both can contribute to the risk. A classic clinical correlation is that OHSS is a risk particularly with **parenteral** administration of gonadotropins, as used in IVF cycles, rather than oral medications like clomiphene. Monitoring and adjusting doses of these medications are crucial to prevent OHSS.

## **Correct Answer:** .